We are excited to share data highlighting NS002’s potential for superior epinephrine absorption and robust formulation stability,” said Dan Teleman, Chief Executive Officer of Nasus Pharma. “Designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results